Acrolein - a pulmonary hazard

Molecular Nutrition and Food Research

Volumn 55, Issue 9, 2011, Pages 1342-1360

  Bein, Kiflai ^a   Leikauf, George D ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

ARDS; Asthma; Carbonyl stress; Chronic obstructive pulmonary disease; Countermeasures

Indexed keywords

ACROLEIN; PROTEIN P53;

ANIMAL; APOPTOSIS; ASTHMA; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COOKING; DNA ADDUCT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; MORTALITY; REVIEW; TOXICITY TESTING;

ACROLEIN; ANIMALS; APOPTOSIS; ASTHMA; BRONCHITIS; COOKING; DNA ADDUCTS; GENE EXPRESSION REGULATION; HUMANS; LUNG NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TOXICITY TESTS, ACUTE; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; NICOTIANA TABACUM;

EID: 80052540632     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100279     Document Type: Review

References (241)

1. Ho, S. S., Yu, J. Z., Chu, K. W., Yeung, L. L., Carbonyl emissions from commercial cooking sources in Hong Kong. J. Air Waste Manag. Assoc. 2006, 56, 1091-1098.
2. Stevens, J. F., Maier, C. S., Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 2008, 52, 7-25.
3. Spada, N., Fujii, E., Cahill, T. M., Diurnal cycles of acrolein and other small aldehydes in regions impacted by vehicle emissions. Environ. Sci. Technol. 2008, 42, 7084-7090.
4. Jermini, C., Weber, A., Grandjean, E., Quantitative determination of various gas-phase components of the side-stream smoke of cigarettes in the room air as a contribution to the problem of passive-smoking (author's transl). Int. Arch. Occup. Environ. Health 1976, 36, 169-181.
5. Nazaroff, W. W., Singer, B. C., Inhalation of hazardous air pollutants from environmental tobacco smoke in US residences. J. Expo. Anal. Environ. Epidemiol. 2004, 14, S71-S77.
6. Weber, A., Jermini, C., Grandjean, E., Irritating effects on man of air pollution due to cigarette smoke. Am. J. Public Health 1976, 66, 672-676.
7. Siegel, M., Involuntary smoking in the restaurant workplace. A review of employee exposure and health effects. J. Am. Med. Assoc. 1993, 270, 490-493.
8. Wilson, M. D., McGlothlin, J. D., Rosenthal, F. S., Black, D. R. et al., Ergonomics. The effect of occupational exposure to environmental tobacco smoke on the heart rate variability of bar and restaurant workers. J. Occup. Environ. Hyg. 2010, 7, D44-D49.
9. Reijula, J. P., Reijula, K. E., The impact of Finnish tobacco legislation on restaurant workers' exposure to tobacco smoke at work. Scand. J. Public Health 2010, 38, 724-730.
10. Gleich, F., Mons, U., Potschke-Langer, M., Air contamination due to smoking in german restaurants, bars, and other venues - before and after the implementation of a partial smoking ban. Nicotine Tob. Res. 2011. (Epub ahead of print).
11. Aharonson, E. F., Menkes, H., Gurtner, G., Swift, D. L., Proctor, D. F., Effect of respiratory airflow rate on removal of soluble vapors by the nose. J. Appl. Physiol. 1974, 37, 654-657.
12. Comey, A., Hahn, D., Dictionary of Chemical Solubilities: Inorganic, Macmillan, New York 1921.
13. Seidell, A., Solubility of Inorganic and Metal Organic Compounds, D. Van Nostrand, New York 1940.
14. Seidell, A., Solubilities of Organic Compounds, D. Van Nostrand., New York 1941.
15. Grace, M. S., Belvisi, M. G., TRPA1 receptors in cough. Pulm. Pharmacol. Ther. 2010, 24, 286-288.
16. Birrell, M. A., Belvisi, M. G., Grace, M., Sadofsky, L. et al., TRPA1 agonists evoke coughing in guinea pig and human volunteers. Am. J. Respir. Crit. Care Med. 2009, 180, 1042-1047.
17. Andre, E., Campi, B., Materazzi, S., Trevisani, M. et al., Cigarette smoke-induced neurogenic inflammation is mediated by alpha, beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J. Clin. Invest. 2008, 118, 2574-2582.
18. Logue, J. M., Small, M. J., Stern, D., Maranche, J., Robinson, A. L., Spatial variation in ambient air toxics concentrations and health risks between industrial-influenced, urban, and rural sites. J. Air Waste Manag. Assoc. 2010, 60, 271-286.
19. Faroon, O., Roney, N., Taylor, J., Ashizawa, A. et al., Acrolein environmental levels and potential for human exposure. Toxicol. Ind. Health 2008, 24, 543-564.
20. USEPA, Acrolein (CASRN 107-02-8). Accessed April 18, 2011, 2003.
21. Ghilarducci, D. P., Tjeerdema, R. S., Fate and effects of acrolein. Rev, Environ, Contam, Toxicol, 1995, 144, 95-146.
22. Morris, J. B., Symanowicz, P. T., Olsen, J. E., Thrall, R. S. et al., Immediate sensory nerve-mediated respiratory responses to irritants in healthy and allergic airway-diseased mice. J. Appl. Physiol. 2003, 94, 1563-1571.
23. Nielsen, G. D., Wolkoff, P., Alarie, Y., Sensory irritation: risk assessment approaches. Regul. Toxicol. Pharmacol. 2007, 48, 6-18.
24. Reddy, S., Finkelstein, E. I., Wong, P. S., Phung, A. et al., Identification of glutathione modifications by cigarette smoke. Free Radic. Biol. Med. 2002, 33, 1490-1498.
25. Love, S., Bratzler, L. J., Tentative identification of carbonyl compounds in wood smoke by gas chromatography. J. Food Sci. 1966, 31, 218-222.
26. Lipari, F., Dasch, J. M., Scruggs, W. F., Aldehyde emissions from wood-burning fireplaces. Environ. Sci. Technol. 1984, 18, 326-330.
27. Ayer, H. E., Yeager, D. W., Irritants in cigarette smoke plumes. Am. J. Public Health 1982, 72, 1283-1285.
28. Chua, M. C., Chan, I. L., Use of central venous lines in paediatrics - a local experience. Ann. Acad. Med. Singapore 1998, 27, 358-362.
29. Holzer, G., Oro, J., Bertsch, W., Gas chromatographic-mass spectrometric evaluation of exhaled tobacco smoke. J. Chromatogr. 1976, 126, 771-785.
30. Hales, C. A., Musto, S. W., Janssens, S., Jung, W. et al., Smoke aldehyde component influences pulmonary edema. J. Appl. Physiol. 1992, 72, 555-561.
31. Magnusson, R., Nilsson, C., Andersson, B., Emissions of aldehydes and ketones from a two-stroke engine using ethanol and ethanol-blended gasoline as fuel. Environ. Sci Technol. 2002, 36, 1656-1664.
32. Zervas, E., Montagne, X., Lahaye, J., Emission of alcohols and carbonyl compounds from a spark ignition engine. Influence of fuel and air/fuel equivalence ratio. Environ. Sci. Technol. 2002, 36, 2414-2421.
33. Song, C., Zhao, Z., Lv, G., Song, J. et al., Carbonyl compound emissions from a heavy-duty diesel engine fueled with diesel fuel and ethanol-diesel blend. Chemosphere 2010, 79, 1033-1039.
34. Grosjean, D., Grosjean, E., Gertler, A. W., On-road emissions of carbonyls from light-duty and heavy-duty vehicles. Environ. Sci. Technol. 2001, 35, 45-53.
35. Woodruff, T. J., Axelrad, D. A., Caldwell, J., Morello-Frosch, R., Rosenbaum, A., Public health implications of 1990 air toxics concentrations across the United States. Environ. Health Perspect. 1998, 106, 245-251.
36. Woodruff, T. J., Wells, E. M., Holt, E. W., Burgin, D. E., Axelrad, D. A., Estimating risk from ambient concentrations of acrolein across the United States. Environ. Health Perspect. 2007, 115, 410-415.
37. Seaman, V., Bennett, D., Cahill, T., Indoor acrolein emission and decay rates resulting from domestic cooking events. Atmospheric Environ. 2009, 43, 6199-6204.
38. Seaman, V. Y., Bennett, D. H., Cahill, T. M., Origin, occurrence, and source emission rate of acrolein in residential indoor air. Environ. Sci. Technol. 2007, 41, 6940-6946.
39. Triebig, G., Zober, M. A., Indoor air pollution by smoke constituents - a survey. Prev. Med. 1984, 13, 570-581.
40. Loefroth, G., Burton, R., Forehand, L., Hammond, S. et al., Characterization of environmental tobacco smoke. Environ. Sci. Technol. 1989, 23, 610-614.
41. OSHA, List of Highly Hazardous Chemicals, Toxics and Reactives (Mandatory). Accessed April 18, 2011.
42. Leikauf, G. D., Hazardous air pollutants and asthma. Environ. Health Perspect. 2002, 110, 505-526.
43. Vasilyev, N., Williams, T., Brennan, M. L., Unzek, S. et al., Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction. Circulation 2005, 112, 2812-2820.
44. Anderson, M. M., Hazen, S. L., Hsu, F. F., Heinecke, J. W., Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha, beta-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 1997, 99, 424-432.
45. Hazen, S. L., Hsu, F. F., d'Avignon, A., Heinecke, J. W., Human neutrophils employ myeloperoxidase to convert alpha-amino acids to a battery of reactive aldehydes: a pathway for aldehyde generation at sites of inflammation. Biochemistry 1998, 37, 6864-6873.
46. Shao, B., Fu, X., McDonald, T. O., Green, P. S. et al., Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. J. Biol. Chem. 2005, 280, 36386-36396.
47. Tabor, C. W., Tabor, H., Bachrach, U., Identification of the aminoaldehydes produced by the oxidation of spermine and spermidine with purified plasma amine oxidase. J. Biol. Chem. 1964, 239, 2194-2203.
48. Houen, G., Bock, K., Jensen, A. L., HPLC and NMR investigation of the serum amine oxidase catalyzed oxidation of polyamines. Acta Chem. Scand. 1994, 48, 52-60.
49. Lee, Y., Sayre, L. M., Reaffirmation that metabolism of polyamines by bovine plasma amine oxidase occurs strictly at the primary amino termini. J. Biol. Chem. 1998, 273, 19490-19494.
50. O'Brien, P. J., Siraki, A. G., Shangari, N., Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit. Rev. Toxicol. 2005, 35, 609-662.
51. Sakata, K., Kashiwagi, K., Sharmin, S., Ueda, S., Igarashi, K., Acrolein produced from polyamines as one of the uraemic toxins. Biochem. Soc. Trans. 2003, 31, 371-374.
52. Esterbauer, H., Schaur, R. J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11, 81-128.
53. Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T. et al., Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 1998, 273, 16058-16066.
54. Furuhata, A., Nakamura, M., Osawa, T., Uchida, K., Thiolation of protein-bound carcinogenic aldehyde. An electrophilic acrolein-lysine adduct that covalently binds to thiols. J. Biol. Chem. 2002, 277, 27919-27926.
55. Corradi, M., Pignatti, P., Manini, P., Andreoli, R. et al., Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur. Respir. J. 2004, 24, 1011-1017.
56. Deshmukh, H. S., Shaver, C., Case, L. M., Dietsch, M. et al., Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am. J. Respir. Cell. Mol. Biol. 2008, 38, 446-454.
57. Morris, J. B., Uptake of acetaldehyde vapor and aldehyde dehydrogenase levels in the upper respiratory tracts of the mouse, rat, hamster, and guinea pig. Fundam. Appl. Toxicol. 1997, 35, 91-100.
58. Folinsbee, L., Human Health Effects of Exposure to Airborne Acid. Environ. Health Perspect. 1989, 79, 195-199.
59. Moldoveanu, S., Coleman III, W., J, W., Determination of carbonyl compounds in exhaled cigarette smoke. Beitr. Tabakforsch Int. 2007, 22, 346-357.
60. Cassee, F. R., Groten, J. P., Feron, V. J., Changes in the nasal epithelium of rats exposed by inhalation to mixtures of formaldehyde, acetaldehyde, and acrolein. Fundam. Appl. Toxicol. 1996, 29, 208-218.
61. Feron, V. J., Kruysse, A., Til, H. P., Immel, H. R., Repeated exposure to acrolein vapour: subacute studies in hamsters, rats and rabbits. Toxicology 1978, 9, 47-57.
62. Leach, C. L., Hatoum, N. S., Ratajczak, H. V., Gerhart, J. M., The pathologic and immunologic effects of inhaled acrolein in rats. Toxicol. Lett. 1987, 39, 189-198.
63. Morris, J. B., Stanek, J., Gianutsos, G., Sensory nerve-mediated immediate nasal responses to inspired acrolein. J. Appl. Physiol. 1999, 87, 1877-1886.
64. Alarie, Y., Sensory irritation by airborne chemicals. CRC Crit. Rev. Toxicol. 1973, 2, 299-363.
65. Buckley, L. A., Jiang, X. Z., James, R. A., Morgan, K. T., Barrow, C. S., Respiratory tract lesions induced by sensory irritants at the RD50 concentration. Toxicol. Appl. Pharmacol. 1984, 74, 417-429.
66. Davis, T. R., Battista, S. P., Kensler, C. J., Mechanism of respiratory effects during exposure of guinea pigs to irritants. Arch. Environ. Health 1967, 15, 412-419.
67. Kane, L. E., Alarie, Y., Sensory irritation to formaldehyde and acrolein during single and repeated exposures in mice. Am. Ind. Hyg. Assoc. J. 1977, 38, 509-522.
68. Murphy, S. D., Klingshirn, D. A., Ulrich, C. E., Respiratory response of guinea pigs during acrolein inhalation and its modification by drugs. J. Pharmacol. Exp. Ther. 1963, 141, 79-83.
69. Nielsen, G. D., Bakbo, J. C., Holst, E., Sensory irritation and pulmonary irritation by airborne allyl acetate, allyl alcohol, and allyl ether compared to acrolein. Acta Pharmacol. Toxicol. (Copenhagen) 1984, 54, 292-298.
70. Steinhagen, W. H., Barrow, C. S., Sensory irritation structure-activity study of inhaled aldehydes in B6C3F1 and Swiss-Webster mice. Toxicol. Appl. Pharmacol. 1984, 72, 495-503.
71. Weber-Tschopp, A., Fischer, T., Gierer, R., Grandjean, E., Experimentally induced irritating effects of acrolein on men (author's transl). Int. Arch. Occup. Environ. Health 1977, 40, 117-130.
72. Cohen, M. A., Guzzardi, L. J., Inhalation of products of combustion. Ann. Emerg. Med. 1983, 12, 628-632.
73. Hales, C. A., Musto, S., Hutchison, W. G., Mahoney, E., BW-755C diminishes smoke-induced pulmonary edema. J. Appl. Physiol. 1995, 78, 64-69.
74. Achauer, B. M., Allyn, P. A., Furnas, D. W., Bartlett, R. H., Pulmonary complications of burns: the major threat to the burn patient. Ann. Surg. 1973, 177, 311-319.
75. Bolstad-Johnson, D. M., Burgess, J. L., Crutchfield, C. D., Storment, S. et al., Characterization of firefighter exposures during fire overhaul. Am. Ind. Hyg. Assoc. J. 2000, 61, 636-641.
76. De Vos, A. J., Reisen, F., Cook, A., Devine, B., Weinstein, P., Respiratory irritants in Australian bushfire smoke: air toxics sampling in a smoke chamber and during prescribed burns. Arch. Environ. Contam. Toxicol. 2009, 56, 380-388.
77. Sterner, J. B., Zanders, T. B., Morris, M. J., Cancio, L. C., Inflammatory mediators in smoke inhalation injury. Inflamm. Allergy Drug Targets 2009, 8, 63-69.
78. Dost, F. N., Acute toxicology of components of vegetation smoke. Rev. Environ. Contam. Toxicol. 1991, 119, 1-46.
79. Toon, M. H., Maybauer, M. O., Greenwood, J. E., Maybauer, D. M., Fraser, J. F., Management of acute smoke inhalation injury. Crit. Care Resusc. 2010, 12, 53-61.
80. Gosselin, B., Wattel, F., Chopin, C., Degand, P. et al., A case of acute acrolein poisoning. Nouv Presse Med. 1979, 8, 2469-2472.
81. Hales, C. A., Barkin, P. W., Jung, W., Trautman, E. et al., Synthetic smoke with acrolein but not HCl produces pulmonary edema. J. Appl. Physiol. 1988, 64, 1121-1133.
82. Janssens, S. P., Musto, S. W., Hutchison, W. G., Spence, C. et al., Cyclooxygenase and lipoxygenase inhibition by BW-755C reduces acrolein smoke-induced acute lung injury. J. Appl. Physiol. 1994, 77, 888-895.
83. Kutzman, R. S., Popenoe, E. A., Schmaeler, M., Drew, R. T., Changes in rat lung structure and composition as a result of subchronic exposure to acrolein. Toxicology 1985, 34, 139-151.
84. Kutzman, R. S., Wehner, R. W., Haber, S. B., Selected responses of hypertension-sensitive and resistant rats to inhaled acrolein. Toxicology 1984, 31, 53-65.
85. Skog, E., A toxicological investigation of lower aliphatic aldehydes Part I. Toxicity of formaldehyde acetaldehyde proprionaldehyde and butyraldehyde as well as acrolein and crotonaldehyde. Acta Pharmacol. Toxicol. 1950, 6, 299-318.
86. Lyon, J. P., Jenkins, L. J., Jr., Jones, R. A., Coon, R. A., Siegel, J., Repeated and continuous exposure of laboratory animals to acrolein. Toxicol. Appl. Pharmacol. 1970, 17, 726-732.
87. Bouley, G., Dubreuil, A., Godin, J., Boudene, C., Effects in the rat of a weak dose of acrolein inhaled continuously. Eur. J. Toxicol. Environ. Hyg. 1975, 8, 291-297.
88. Bouley, G., Dubreuil, A., Godin, J., Boisset, M., Boudene, C., Phenomena of adaptation in rats continuously exposed to low concentrations of acrolein. Ann. Occup. Hyg. 1976, 19, 27-32.
89. Jakab, G. J., Adverse effect of a cigarette smoke component, acrolein, on pulmonary antibacterial defenses and on viral-bacterial interactions in the lung. Am. Rev. Respir. Dis. 1977, 115, 33-38.
90. Astry, C. L., Jakab, G. J., The effects of acrolein exposure on pulmonary antibacterial defenses. Toxicol. Appl. Pharmacol. 1983, 67, 49-54.
91. Aranyi, C., O'Shea, W. J., Graham, J. A., Miller, F. J., The effects of inhalation of organic chemical air contaminants on murine lung host defenses. Fundam. Appl. Toxicol. 1986, 6, 713-720.
92. Jakab, G. J., The toxicologic interactions resulting from inhalation of carbon black and acrolein on pulmonary antibacterial and antiviral defenses. Toxicol. Appl. Pharmacol. 1993, 121, 167-175.
93. Shang, S., Ordway, D., Henao-Tamayo, M., Bai, X. et al., Cigarette smoke increases susceptibility to tuberculosis - evidence from in vivo and in vitro models. J. Infect. Dis. 2011, 203, 1240-1248.
94. Jang, A. S., Concel, V. J., Bein, K., Brant, K. A. et al., Endothelial dysfunction and claudin 5 regulation during acrolein-induced lung injury. Am. J. Respir. Cell. Mol. Biol. 2010, 44, 483-490.
95. Leikauf, G. D., Concel, V. J., Liu, P., Bein, K. et al., Haplotype association mapping of acute lung injury in mice implicates activin A receptor, type 1. Am. J. Respir. Crit. Care Med. 2011, 183, 1499-1503.
96. Wenzel, S. E., Asthma: defining of the persistent adult phenotypes. Lancet 2006, 368, 804-813.
97. NHLBI Expert Panel Report 3, Guidelines for the Diagnosis and Management of Asthma Clinical Practice Guidelines National Asthma Education and Prevention Program, Third Expert Panel on the Diagnosis and Management of Asthma, Bethesda, MD 2007.
98. Leikauf, G. D., Leming, L. M., O'Donnell, J. R., Doupnik, C. A., Bronchial responsiveness and inflammation in guinea pigs exposed to acrolein. J. Appl. Physiol. 1989, 66, 171-178.
99. Leikauf, G. D., Doupnik, C. A., Leming, L. M., Wey, H. E., Sulfidopeptide leukotrienes mediate acrolein-induced bronchial hyperresponsiveness. J. Appl. Physiol. 1989, 66, 1838-1845.
100. Doupnik, C. A., Leikauf, G. D., Acrolein stimulates eicosanoid release from bovine airway epithelial cells. Am. J. Physiol. 1990, 259, L222-229.
101. Roux, E., Hyvelin, J. M., Savineau, J. P., Marthan, R., Human isolated airway contraction: interaction between air pollutants and passive sensitization. Am. J. Respir. Crit. Care Med. 1999, 160, 439-445.
102. Mannino, D. M., Homa, D. M., Akinbami, L. J., Ford, E. S., Redd, S. C., Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill. Summ. 2002, 51, 1-16.
103. American Thoracic Society, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995, 152, S77-S121.
104. Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S. et al., International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007, 370, 741-750.
105. Eisner, M. D., Anthonisen, N., Coultas, D., Kuenzli, N. et al., An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010, 182, 693-718.
106. Vestbo, J., Hogg, J. C., Convergence of the epidemiology and pathology of COPD. Thorax 2006, 61, 86-88.
107. Dennis, R. J., Maldonado, D., Norman, S., Baena, E. et al., Wood smoke exposure and risk for obstructive airways disease among women. Chest 1996, 109, 55S-56S.
108. Barnes, P. J., Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med. 2007, 4, e112.
109. DeMeo, D. L., Silverman, E. K., Genetics of chronic obstructive pulmonary disease. Semin. Respir. Crit. Care Med. 2003, 24, 151-160.
110. Jeffery, P. K., Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture. Chest 2000, 117, 251S-260S.
111. Rogers, D. F., Mucoactive agents for airway mucus hypersecretory diseases. Respir. Care 2007, 52, 1176-1193.
112. Del Donno, M., Bittesnich, D., Chetta, A., Olivieri, D., Lopez-Vidriero, M. T., The effect of inflammation on mucociliary clearance in asthma: an overview. Chest 2000, 118, 1142-1149.
113. Lai, H., Rogers, D. F., New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways. J. Aerosol Med. Pulm. Drug Deliv. 2010, 23, 219-231.
114. Leikauf, G. D., Borchers, M. T., Prows, D. R., Simpson, L. G., Mucin apoprotein expression in COPD. Chest 2002, 121, 166S-182S.
115. Ali, M. S., Pearson, J. P., Upper airway mucin gene expression: a review. Laryngoscope 2007, 117, 932-938.
116. Voynow, J. A., What does mucin have to do with lung disease? Paediatr. Respir. Rev. 2002, 3, 98-103.
117. Hovenberg, H. W., Davies, J. R., Herrmann, A., Linden, C. J., Carlstedt, I., MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions. Glycoconj. J. 1996, 13, 839-847.
118. Sheehan, J. K., Howard, M., Richardson, P. S., Longwill, T., Thornton, D. J., Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug. Biochem. J. 1999, 338, 507-513.
119. Hovenberg, H. W., Davies, J. R., Carlstedt, I., Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. Biochem. J. 1996, 318, 319-324.
120. Thornton, D. J., Howard, M., Khan, N., Sheehan, J. K., Identification of two glycoforms of the MUC5B mucin in human respiratory mucus. Evidence for a cysteine-rich sequence repeated within the molecule. J. Biol. Chem. 1997, 272, 9561-9566.
121. Guan, A. Y., Xu, Z. B., Wen, F. Q., Wang, B. D., Feng, Y. L., Effect of gefinitib on airway mucus hypersecretion induced by acrolein in rats. Sichuan Da Xue Xue Bao Yi Xue Ban 2008, 39, 231-234.
122. Borchers, M. T., Wert, S. E., Leikauf, G. D., Acrolein-induced MUC5ac expression in rat airways. Am. J. Physiol. 1998, 274, L573-581.
123. Borchers, M. T., Carty, M. P., Leikauf, G. D., Regulation of human airway mucins by acrolein and inflammatory mediators. Am. J. Physiol. 1999, 276, L549-555.
124. Haswell, L. E., Hewitt, K., Thorne, D., Richter, A., Gaca, M. D., Cigarette smoke total particulate matter increases mucous secreting cell numbers in vitro: a potential model of goblet cell hyperplasia. Toxicol. In Vitro 2010, 24, 981-987.
125. Takeyama, K., Dabbagh, K., Lee, H. M., Agusti, C. et al., Epidermal growth factor system regulates mucin production in airways. Proc. Natl. Acad. Sci. USA 1999, 96, 3081-3086.
126. Perrais, M., Pigny, P., Copin, M. C., Aubert, J. P., Van Seuningen, I., Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1. J. Biol. Chem. 2002, 277, 32258-32267.
127. Shim, J. J., Dabbagh, K., Ueki, I. F., Dao-Pick, T. et al., IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280, L134-140.
128. Takeyama, K., Jung, B., Shim, J. J., Burgel, P. R. et al., Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 280, L165-172.
129. Kohri, K., Ueki, I. F., Nadel, J. A., Neutrophil elastase induces mucin production by ligand-dependent epidermal growth factor receptor activation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283, L531-540.
130. Cowell, S., Knauper, V., Stewart, M. L., D'Ortho, M. P. et al., Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem. J. 1998, 331, 453-458.
131. Deshmukh, H. S., McLachlan, A., Atkinson, J. J., Hardie, W. D. et al., Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am. J. Respir. Crit. Care Med. 2009, 180, 834-845.
132. Liu, D. S., Wang, T., Han, S. X., Dong, J. J. et al., p38 MAPK and MMP-9 cooperatively regulate mucus overproduction in mice exposed to acrolein fog. Int. Immunopharmacol. 2009, 9, 1228-1235.
133. Chen, Y. J., Chen, P., Wang, H. X., Wang, T. et al., Simvastatin attenuates acrolein-induced mucin production in rats: involvement of the Ras/extracellular signal-regulated kinase pathway. Int. Immunopharmacol. 2010, 10, 685-693.
134. Liu, D. S., Liu, W. J., Chen, L., Ou, X. M. et al., Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats. Toxicology 2009, 260, 112--119.
135. Hogg, J. C., Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004, 364, 709-721.
136. NHLBI, The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Dvision of Lung Diseases Workshop. Am. Rev. Respir. Dis. 1985, 132, 182-185.
137. Shapiro, S. D., Ingenito, E. P., The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am. J. Respir. Cell. Mol. Biol. 2005, 32, 367-372.
138. Laurell, C. B., Eriksson, S., The electrophoretic alpha-1-globulin pattern of serum in alpha-1-antitrypsin deficiency. Scand. J. Clin. Invest. 1963, 15, 132-140.
139. Gross, P., Pfitzer, E. A., Tolker, E., Babyak, M. A., Kaschak, M., Experimental emphysema: its production with papain in normal and silicotic rats. Arch. Environ. Health 1965, 11, 50-58.
140. Shapiro, S. D., Goldstein, N. M., Houghton, A. M., Kobayashi, D. K. et al., Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am. J. Pathol. 2003, 163, 2329-2335.
141. Hautamaki, R. D., Kobayashi, D. K., Senior, R. M., Shapiro, S. D., Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997, 277, 2002-2004.
142. Churg, A., Wang, R. D., Xie, C., Wright, J. L., alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am. J. Respir. Crit. Care Med. 2003, 168, 199-207.
143. Churg, A., Wang, X., Wang, R. D., Meixner, S. C. et al., Alpha1-antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophages. Am. J. Respir. Cell. Mol. Biol. 2007, 37, 144-151.
144. Mahadeva, R., Lomas, D. A., Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 1998, 53, 501-505.
145. Senior, R. M., Griffin, G. L., Fliszar, C. J., Shapiro, S. D. et al., Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 1991, 266, 7870-7875.
146. Shapiro, S. D., Kobayashi, D. K., Ley, T. J., Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 1993, 268, 23824-23829.
147. D'Armiento, J., Dalal, S. S., Okada, Y., Berg, R. A., Chada, K., Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 1992, 71, 955-961.
148. Churg, A., Wang, R. D., Tai, H., Wang, X. et al., Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am J. Respir. Crit. Care Med. 2003, 167, 1083-1089.
149. Kuhn, C., Yu, S. Y., Chraplyvy, M., Linder, H. E., Senior, R. M., The induction of emphysema with elastase. II. Changes in connective tissue. Lab Invest. 1976, 34, 372-380.
150. Senior, R. M., Tegner, H., Kuhn, C., Ohlsson, K. et al., The induction of pulmonary emphysema with human leukocyte elastase. Am. Rev. Respir. Dis. 1977, 116, 469-475.
151. Janoff, A., Sloan, B., Weinbaum, G., Damiano, V. et al., Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am. Rev. Respir. Dis. 1977, 115, 461-478.
152. Snider, G. L., Lucey, E. C., Christensen, T. G., Stone, P. J. et al., Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products. Am. Rev. Respir. Dis. 1984, 129, 155-160.
153. Kao, R. C., Wehner, N. G., Skubitz, K. M., Gray, B. H., Hoidal, J. R., Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J. Clin. Invest. 1988, 82, 1963-1973.
154. Chapman, H. A., Jr., Stone, O. L., Vavrin, Z., Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation. J. Clin. Invest. 1984, 73, 806-815.
155. Apte, S. S., Fukai, N., Beier, D. R., Olsen, B. R., The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis. J. Biol. Chem. 1997, 272, 25511-25517.
156. Oblander, S. A., Zhou, Z., Galvez, B. G., Starcher, B. et al., Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation. Dev. Biol. 2005, 277, 255-269.
157. Di Stefano, A., Capelli, A., Lusuardi, M., Balbo, P. et al., Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am. J. Respir. Crit. Care Med. 1998, 158, 1277-1285.
158. Pesci, A., Balbi, B., Majori, M., Cacciani, G. et al., Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur. Respir. J. 1998, 12, 380-386.
159. + T lymphocytes with FEV1. Am. J. Respir. Crit. Care Med. 1997, 155, 852-857.
160. Keatings, V. M., Collins, P. D., Scott, D. M., Barnes, P. J., Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 1996, 153, 530-534.
161. Tetley, T. D., Macrophages and the pathogenesis of COPD. Chest 2002, 121, 156S-159S.
162. Ohnishi, K., Takagi, M., Kurokawa, Y., Satomi, S., Konttinen, Y. T., Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest. 1998, 78, 1077-1087.
163. Chung, K. F., Cytokines in chronic obstructive pulmonary disease. Eur. Respir. J. Suppl. 2001, 34, 50s-59s.
164. Borchers, M. T., Wesselkamper, S., Wert, S. E., Shapiro, S. D., Leikauf, G. D., Monocyte inflammation augments acrolein-induced Muc5ac expression in mouse lung. Am. J. Physiol. 1999, 277, L489-497.
165. Barnes, P. J., Chronic obstructive pulmonary disease. N. Engl. J. Med. 2000, 343, 269-280.
166. + T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. J. Immunol. 2007, 178, 8090-8096.
167. Borchers, M. T., Wesselkamper, S. C., Harris, N. L., Deshmukh, H. et al., CD8+ T cells contribute to macrophage accumulation and airspace enlargement following repeated irritant exposure. Exp. Mol. Pathol. 2007, 83, 301-310.
168. Small, B. A., Dressel, S. A., Lawrence, C. W., Drake, D. R., 3rd et al., CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells. J. Exp. Med. 2001, 194, 1835-1846.
169. Grumelli, S., Corry, D. B., Song, L. Z., Song, L. et al., An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 2004, 1, e8.
170. Borchers, M. T., Wesselkamper, S. C., Eppert, B. L., Motz, G. T. et al., Nonredundant functions of alphabeta and gammadelta T cells in acrolein-induced pulmonary pathology. Toxicol. Sci. 2008, 105, 188-199.
171. Borchers, M. T., Wesselkamper, S. C., Deshmukh, H., Beckman, E. et al., The role of T cells in the regulation of acrolein-induced pulmonary inflammation and epithelial-cell pathology. Res. Rep. Health Eff. Inst. 2009, 146, 5-29.
172. Wang, H. T., Zhang, S., Hu, Y., Tang, M. S., Mutagenicity and sequence specificity of acrolein-DNA adducts. Chem. Res. Toxicol. 2009, 22, 511-517.
173. Feng, Z., Hu, W., Hu, Y., Tang, M. S., Acrolein is a major cigarette-related lung cancer agent: preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc. Natl. Acad. Sci. USA 2006, 103, 15404-15409.
174. 2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res. 1984, 44, 990-995.
175. Kim, S. I., Pfeifer, G. P., Besaratinia, A., Lack of mutagenicity of acrolein-induced DNA adducts in mouse and human cells. Cancer Res. 2007, 67, 11640-11647.
176. 2-propanodeoxyguanosine adducts in human leukocyte DNA from smokers and nonsmokers. Chem. Res. Toxicol. 2011, 24, 119-124.
177. IARC, IARC monographs on the evaluation of carcinogenic risks to humans: dry cleaning, some chlorinated solvents and other industrial chemicals, WHO 1997.
178. Hecht, S. S., Smoking and lung cancer - a new role for an old toxicant? Proc. Natl. Acad. Sci. USA 2006, 103, 15725-15726.
179. Biswal, S., Maxwell, T., Rangasamy, T., Kehrer, J. P., Modulation of benzo[a]pyrene-induced p53 DNA activity by acrolein. Carcinogenesis 2003, 24, 1401-1406.
180. IARC, IARC monographs on the evaluation of carcinogenic risks to humans, Suppl. 7, Overall evaluations of carcinogenicity: an updating of lARC Monographs 1987, p. 64.
181. Beauchamp, R. O., Jr., Andjelkovich, D. A., Kligerman, A. D., Morgan, K. T., Heck, H. D., A critical review of the literature on acrolein toxicity. Crit. Rev. Toxicol. 1985, 14, 309-380.
182. Grafstrom, R. C., Dypbukt, J. M., Willey, J. C., Sundqvist, K. et al., Pathobiological effects of acrolein in cultured human bronchial epithelial cells. Cancer Res. 1988, 48, 1717-1721.
183. Li, L., Hamilton, R. F., Jr., Taylor, D. E., Holian, A., Acrolein-induced cell death in human alveolar macrophages. Toxicol. Appl. Pharmacol. 1997, 145, 331-339.
184. Hoshino, Y., Mio, T., Nagai, S., Miki, H. et al., Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281, L509-516.
185. Nardini, M., Finkelstein, E. I., Reddy, S., Valacchi, G. et al., Acrolein-induced cytotoxicity in cultured human bronchial epithelial cells. Modulation by alpha-tocopherol and ascorbic acid. Toxicology 2002, 170, 173-185.
186. Jia, L., Zhang, Z., Zhai, L., Bai, Y., Protective effect of lipoic acid against acrolein-induced cytotoxicity in IMR-90 human fibroblasts. J. Nutr. Sci. Vitaminol. (Tokyo) 2009, 55, 126-130.
187. Finkelstein, E. I., Nardini, M., van der Vliet, A., Inhibition of neutrophil apoptosis by acrolein: a mechanism of tobacco-related lung disease? Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, 281, L732-L739.
188. Finkelstein, E. I., Ruben, J., Koot, C. W., Hristova, M., van der Vliet, A., Regulation of constitutive neutrophil apoptosis by the alpha, beta-unsaturated aldehydes acrolein and 4-hydroxynonenal. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289, L1019-1028.
189. Cross, C. E., O'Neill, C. A., Reznick, A. Z., Hu, M. L. et al., Cigarette smoke oxidation of human plasma constituents. Ann. NY Acad. Sci. 1993, 686, 72-89; discussion 89-90.
190. Eiserich, J. P., van der Vliet, A., Handelman, G. J., Halliwell, B., Cross, C. E., Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am. J. Clin. Nutr. 1995, 62, 1490S-1500S.
191. Burcham, P. C., Raso, A., Thompson, C. A., Intermediate filament carbonylation during acute acrolein toxicity in A549 lung cells: functional consequences, chaperone redistribution, and protection by bisulfite. Antioxid. Redox Signal. 2010, 12, 337-347.
192. Horton, N. D., Mamiya, B. M., Kehrer, J. P., Relationships between cell density, glutathione and proliferation of A549 human lung adenocarcinoma cells treated with acrolein. Toxicology 1997, 122, 111-122.
193. Aoshiba, K., Yasui, S., Nishimura, K., Nagai, A., Thiol depletion induces apoptosis in cultured lung fibroblasts. Am. J. Respir. Cell. Mol. Biol. 1999, 21, 54-64.
194. Rudra, P. K., Krokan, H. E., Acrolein cytotoxicity and glutathione depletion in n-3 fatty acid sensitive- and resistant human tumor cells. Anticancer Res. 1999, 19, 461-469.
195. Tirumalai, R., Rajesh Kumar, T., Mai, K. H., Biswal, S., Acrolein causes transcriptional induction of phase II genes by activation of Nrf2 in human lung type II epithelial (A549) cells. Toxicol. Lett. 2002, 132, 27-36.
196. Buchmuller-Rouiller, Y., Corrandin, S. B., Smith, J., Schneider, P. et al., Role of glutathione in macrophage activation: effect of cellular glutathione depletion on nitrite production and leishmanicidal activity. Cell Immunol. 1995, 164, 73-80.
197. Rouzer, C. A., Scott, W. A., Griffith, O. W., Hamill, A. L., Cohn, Z. A., Depletion of glutathione selectively inhibits synthesis of leukotriene C by macrophages. Proc. Natl. Acad. Sci. USA 1981, 78, 2532-2536.
198. Hansen, J. M., Zhang, H., Jones, D. P., Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions. Free Radic. Biol. Med. 2006, 40, 138-145.
199. Roy, J., Pallepati, P., Bettaieb, A., Tanel, A., Averill-Bates, D. A., Acrolein induces a cellular stress response and triggers mitochondrial apoptosis in A549 cells. Chem. Biol. Interact. 2009, 181, 154-167.
200. Roy, J., Pallepati, P., Bettaieb, A., Averill-Bates, D. A., Acrolein induces apoptosis through the death receptor pathway in A549 lung cells: role of p53. Can. J. Physiol. Pharmacol. 2010, 88, 353-368.
201. Myers, C. R., Myers, J. M., The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells. Toxicology 2009, 257, 95-104.
202. Church, D. F., Pryor, W. A., Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect. 1985, 64, 111-126.
203. Leanderson, P., Tagesson, C., Cigarette smoke-induced DNA damage in cultured human lung cells: role of hydroxyl radicals and endonuclease activation. Chem. Biol. Interact. 1992, 81, 197-208.
204. Pryor, W. A., Stone, K., Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann. NY Acad. Sci. 1993, 686, 12-27.
205. Frei, B., Forte, T. M., Ames, B. N., Cross, C. E., Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem. J. 1991, 277, 133-138.
206. Reznick, A. Z., Cross, C. E., Hu, M. L., Suzuki, Y. J. et al., Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. Biochem. J. 1992, 286, 607-611.
207. Eiserich, J. P., Vossen, V., O'Neill, C. A., Halliwell, B. et al., Molecular mechanisms of damage by excess nitrogen oxides: nitration of tyrosine by gas-phase cigarette smoke. FEBS Lett. 1994, 353, 53-56.
208. O'Neill, C. A., Halliwell, B., van der Vliet, A., Davis, P. A. et al., Aldehyde-induced protein modifications in human plasma: protection by glutathione and dihydrolipoic acid. J. Lab. Clin. Med. 1994, 124, 359-370.
209. Lannan, S., Donaldson, K., Brown, D., MacNee, W., Effect of cigarette smoke and its condensates on alveolar epithelial cell injury in vitro. Am. J. Physiol. 1994, 266, L92-100.
210. Wang, H., Liu, X., Umino, T., Skold, C. M. et al., Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am. J. Respir. Cell. Mol. Biol. 2001, 25, 772-779.
211. Carnevali, S., Nakamura, Y., Mio, T., Liu, X. et al., Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction. Am. J. Physiol. 1998, 274, L591-598.
212. Holsapple, M. P., Wallace, K. B., Dose response considerations in risk assessment - an overview of recent ILSI activities. Toxicol. Lett. 2008, 180, 85-92.
213. Kilburn, K. H., McKenzie, W. N., Leukocyte recruitment to airways by aldehyde-carbon combinations that mimic cigarette smoke. Lab Invest. 1978, 38, 134-142.
214. Ben-Jebria, A., Crozet, Y., Eskew, M. L., Rudeen, B. L., Ultman, J. S., Acrolein-induced smooth muscle hyperresponsiveness and eicosanoid release in excised ferret tracheae. Toxicol. Appl. Pharmacol. 1995, 135, 35-44.
215. Turner, C. R., Stow, R. B., Hubbs, S. J., Gomes, B. C., Williams, J. C., Acrolein increases airway sensitivity to substance P and decreases NEP activity in guinea pigs. J. Appl. Physiol. 1993, 74, 1830-1839.
216. Dahlgren, S. E., Dalen, H., Dalhamm, T., Ultrastructural observations on chemically induced inflammation in guinea pig trachea. Virchows Arch. B Cell. Pathol. 1972, 11, 211-223.
217. Romet, S., Dubreuil, A., Baeza, A., Moreau, A. et al., Respiratory tract epithelium in primary culture: Effects of ciliotoxic compounds. Toxicol In Vitro 1990, 4, 399-402.
218. Romet-Haddad, S., Marano, F., Blanquart, C., Baeza-Squiban, A., Tracheal epithelium in culture: a model for toxicity testing of inhaled molecules. Cell. Biol. Toxicol. 1992, 8, 141-150.
219. Powell, G. M., Green, G. M., Cigarette smoke - a proposed metabolic lesion in alveolar macrophages. Biochem. Pharmacol. 1972, 21, 1785-1798.
220. Low, E. S., Low, R. B., Green, G. M., Correlated effects of cigarette smoke components on alveolar macrophage adenosine triphosphatase activity and phagocytosis. Am. Rev. Respir. Dis. 1977, 115, 963-970.
221. Li, L., Hamilton, R. F., Jr., Holian, A., Effect of acrolein on human alveolar macrophage NF-kappaB activity. Am. J. Physiol. 1999, 277, L550-557.
222. Li, L., Holian, A., Acrolein: a respiratory toxin that suppresses pulmonary host defense. Rev. Environ. Health 1998, 13, 99-108.
223. Burcham, P. C., Raso, A., Thompson, C., Tan, D., Intermolecular protein cross-linking during acrolein toxicity: efficacy of carbonyl scavengers as inhibitors of heat shock protein-90 cross-linking in A549 cells. Chem. Res. Toxicol. 2007, 20, 1629-1637.
224. van der Toorn, M., Smit-de Vries, M. P., Slebos, D. J., de Bruin, H. G. et al., Cigarette smoke irreversibly modifies glutathione in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293, L1156-1162.
225. Burcham, P. C., Raso, A., Thompson, C. A., Toxicity of smoke extracts towards A549 lung cells: role of acrolein and suppression by carbonyl scavengers. Chem. Biol. Interact. 2010, 183, 416-424.
226. Lambert, C., Li, J., Jonscher, K., Yang, T. C. et al., Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain. J. Biol. Chem. 2007, 282, 19666-19675.
227. Horton, N. D., Biswal, S. S., Corrigan, L. L., Bratta, J., Kehrer, J. P., Acrolein causes inhibitor kappaB-independent decreases in nuclear factor kappaB activation in human lung adenocarcinoma (A549) cells. J. Biol. Chem. 1999, 274, 9200-9206.
228. Biswal, S., Acquaah-Mensah, G., Datta, K., Wu, X., Kehrer, J. P., Inhibition of cell proliferation and AP-1 activity by acrolein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications. Chem. Res. Toxicol. 2002, 15, 180-186.
229. 2-propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionization-tandem mass spectrometry. Chem. Res. Toxicol. 2007, 20, 565-571.
230. Sarkar, P., Hayes, B. E., Proteomic profiling of rat lung epithelial cells induced by acrolein. Life Sci. 2009, 85, 188-195.
231. Thompson, C. A., Burcham, P. C., Genome-wide transcriptional responses to acrolein. Chem. Res. Toxicol. 2008, 21, 2245-2256.
232. Valacchi, G., Pagnin, E., Phung, A., Nardini, M. et al., Inhibition of NFkappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxid. Redox Signal. 2005, 7, 25-31.
233. Kasahara, D. I., Poynter, M. E., Othman, Z., Hemenway, D., van der Vliet, A., Acrolein inhalation suppresses lipopolysaccharide-induced inflammatory cytokine production but does not affect acute airways neutrophilia. J. Immunol. 2008, 181, 736-745.
234. Vainiotalo, S., Matveinen, K., Cooking fumes as a hygienic problem in the food and catering industries. Am. Ind. Hyg. Assoc. J. 1993, 54, 376-382.
235. Hirayama, T., Yamaguchi, M., Nakata, T., Okumura, M. et al., Formation of acrolein by the autooxidation of unsaturated fatty acid methyl esters. Eisei Kagaku 1989, 35, 303-306.
236. Einhorn, I. N., Physiological and toxicological aspects of smoke produced during the combustion of polymeric materials. Environ. Health Perspect. 1975, 11, 163-189.
237. McDonald, J., Zielinska, B., Fujita, E., Sagebiel, J. et al., Fine particle and gaseous emission rates from residential wood combustion. Environ. Sci. Technol. 2000, 34, 2080-2091.
238. R. J. Reynolds Tobacco Company, Chemical Composition of New Cigarette Smoke. In: Chemical and Biological Studies on New Cigarette Prototypes that Heat Instead of Burn Tobacco. R. J. Reynolds Tobacco Company, Winston-Salem NC 1988.
239. Hoffmann, D., Brunnemann, K. D., Gori, G. B., Wynder, E. L., On the carcinogenicity of marijuana smoke, Rec. Adv. Phytochem. 1975, 9, 63-81.
240. Horton, A. D., Guerin, M. R., Determination of acetaldehydes and acrolein in the gas phase of cigarette smoke using cryothermal gas chromatography. Tob. Sci. 1974, 176, 45-48.
241. Ramu, K., Perry, C. S., Ahmed, T., Pakenham, G., Kehrer, J. P., Studies on the basis for the toxicity of acrolein mercapturates. Toxicol. Appl. Pharmacol. 1996, 140, 487-498.